Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion type Assertion NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_head.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion wasGeneratedBy ECO_0000203 NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_provenance.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion wasDerivedFrom befree-20150227 NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_provenance.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion SIO_000772 14676836 NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_provenance.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion evidence source_evidence_literature NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_provenance.
- NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_assertion description "[The oncogene Bcl-2 is upregulated frequently in prostate tumors following androgen ablation therapy, and Bcl-2 overexpression may contribute to the androgen-refractory relapse of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262660.RAxdbbDhRjQR9uqUt-295az60wt7BbxPHqxRmvINpROfc130_provenance.